![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2021
Kremsner, Peter G.; Mann, Philipp; Kroidl, Arne; Leroux-Roels, Isabel; Schindler, Christoph; Gabor, Julian J.; Schunk, Mirjam; Leroux-Roels, Geert; Bosch, Jacobus J.; Fendel, Rolf; Kreidenweiss, Andrea; Velavan, Thirumalaisamy P.; Fotin-Mleczek, Mariola; Mueller, Stefan O.; Quintini, Gianluca; Schoenborn-Kellenberger, Oliver; Vahrenhorst, Dominik; Verstraeten, Thomas; de Mesquita, Margarida Alves; Walz, Lisa; Wolz, Olaf-Oliver und Oostvogels, Lidia
(2021):
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 A phase 1 randomized clinical trial.
In: Wiener Klinische Wochenschrift, Bd. 133, Nr. 17-18: S. 931-941
2020
Jakubovski, Ewgeni; Pisarenko, Anna; Fremer, Carolin; Haas, Martina; May, Marcus; Schumacher, Carsten; Schindler, Christoph; Hackl, Sebastian; Davila, Lukas Aguirre; Koch, Armin; Brunnauer, Alexander; Cimpianu, Camelia Lucia; Lutz, Beat; Bindila, Laura und Müller-Vahl, Kirsten
(November 2020):
The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders.
In: Frontiers in Psychiatry, Bd. 11, 575826: S. 1-10
[PDF, 1MB]